fecal transplant

by King’s College London edited by Stephanie Baum, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Biosynthetic diversity analysis of RiPPs in colonizing bacteria after FMT. Credit: Gut Microbes (2026). DOI: 10.1080/19490976.2026.2634469 Scientists have identified why some gut microbes successfully stay in the gut after fecal transplants, while others are much more transient. The King’s College […]

by Miriam Fauzia edited by Sadie Harley, reviewed by Andrew Zinin  Editors’ notes  The GIST Add as preferred source Credit: Pixabay/CC0 Public Domain One person’s waste could be another’s shot at fighting cancer. The idea may sound far-fetched, but it is gaining momentum in cancer care. Researchers are testing fecal microbiota transplants as a way of changing

by London Health Sciences Centre Research Institute edited by Gaby Clark, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Above: Saman Maleki, Ph.D., holding a ‘poop pill’ developed by Lawson Research Institute (Lawson) of St. Joseph’s Health Care London and tested in clinical trials at London Health Sciences Centre Research Institute (LHSCRI) and Centre

By Dr. Sanchari Sinha Dutta, Ph.D.Reviewed by Lauren HardakerAug 5, 2025 Doctors tested fecal transplants from donor gut bacteria in frail hospital patients. Could this be the next tool to fight deadly drug-resistant infections? Study: Microbiota Transplantation Among Patients Receiving Long-Term Care. Image credit: 3dMediSphere/Shutterstock.com A non-randomized clinical trial examining the safety and acceptability of fecal microbiota transplantation

by Kendall Daniels Rovinsky, University of North Carolina at Chapel Hill School of Medicine edited by Lisa Lock, reviewed by Andrew Zinin   Credit: University of North Carolina at Chapel Hill School of Medicine A new comparative study led by researchers at the UNC School of Medicine found that a new therapy for prevention of recurrent Clostridioides difficile

by University of Chicago edited by Sadie Harley, reviewed by Robert Egan   Credit: Pixabay/CC0 Public Domain Fecal microbiota transplants (FMT) have been touted as a potential treatment for a variety of conditions, from inflammatory bowel diseases, obesity, and type 2 diabetes to autism. New research from the University of Chicago, however, cautions against widespread use of FMT